These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24615680)

  • 1. Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance.
    Singh AK; Arya RK; Maheshwari S; Singh A; Meena S; Pandey P; Dormond O; Datta D
    Int J Cancer; 2015 May; 136(9):1991-2000. PubMed ID: 24615680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence cancer stem cells--made by cell fusion?
    Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
    Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The concept and significance of cancer stem cells].
    Haraguchi N; ishii H; Sakai D; Satoh T; Doki Y; Mori M
    Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):204-9. PubMed ID: 22582581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
    Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
    Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.
    Fábián Á; Vereb G; Szöllősi J
    Cytometry A; 2013 Jan; 83(1):62-71. PubMed ID: 22997049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the cell of origin in breast cancer and breast cancer stem cells.
    Lindeman GJ; Visvader JE
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells and their potential implications for the treatment of solid tumors.
    Grotenhuis BA; Wijnhoven BP; van Lanschot JJ
    J Surg Oncol; 2012 Aug; 106(2):209-15. PubMed ID: 22371125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells.
    Guo W; Lasky JL; Wu H
    Pediatr Res; 2006 Apr; 59(4 Pt 2):59R-64R. PubMed ID: 16549550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
    Chiba T; Kamiya A; Yokosuka O; Iwama A
    Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cell niche: the place to be.
    Borovski T; De Sousa E Melo F; Vermeulen L; Medema JP
    Cancer Res; 2011 Feb; 71(3):634-9. PubMed ID: 21266356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells in solid tumors.
    Ailles LE; Weissman IL
    Curr Opin Biotechnol; 2007 Oct; 18(5):460-6. PubMed ID: 18023337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells.
    Williams JL
    Clin Lab Sci; 2012; 25(1):50-7. PubMed ID: 22458050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf.
    Dzobo K; Senthebane DA; Rowe A; Thomford NE; Mwapagha LM; Al-Awwad N; Dandara C; Parker MI
    OMICS; 2016 Dec; 20(12):681-691. PubMed ID: 27930094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells and self-renewal.
    O'Brien CA; Kreso A; Jamieson CH
    Clin Cancer Res; 2010 Jun; 16(12):3113-20. PubMed ID: 20530701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.
    Shibuya K; Okada M; Suzuki S; Seino M; Seino S; Takeda H; Kitanaka C
    Oncotarget; 2015 Jan; 6(2):651-61. PubMed ID: 25528771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity of cancer stem cells.
    Sugihara E; Saya H
    Int J Cancer; 2013 Mar; 132(6):1249-59. PubMed ID: 23180591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells: current status and evolving complexities.
    Visvader JE; Lindeman GJ
    Cell Stem Cell; 2012 Jun; 10(6):717-728. PubMed ID: 22704512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.